Select Medical Q3 revenue up 5.7% to $1.76B; net income +33.2%; dividend $0.125; FY guidance updated

SELECT MEDICAL HOLDINGS CORP

2024-Q3 EPS reported $1.78 revenue$5,309,692,000

Q3 revenue $1,761.2M (+5.7% YoY); net income $81.0M (+33.2%); adjusted EPS $0.50 (+8.7%).
Segment Adj. EBITDA: Critical Illness +9.5%, Rehab Hospital +12.1%, Concentra +2.7%.
FY2024 guidance: revenue $6.95B–$7.15B; Adj. EBITDA $865M–$885M; adj. EPS $2.09–$2.20.
Dividend $0.125/share declared, payable Nov 26 to holders of record Nov 13, 2024.
No share repurchases in Q3; $600.3M total buybacks since program inception.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.